1. Hrusak, O, Kalina, T, Wolf, J, et al. Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment. Eur J Cancer 2020; 132: 11–16.
Google Scholar | Crossref | Medline2. Zimmermann, P, Curtis, N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch Dis Child. Epub ahead of print Dec 1, 2020. DOI: 10.1136/archdischild-2020-320338
Google Scholar | Crossref3. Saab, R, Obeid, A, Gachi, F, et al. Impact of the coronavirus disease 2019 (COVID-19) pandemic on pediatric oncology care in the Middle East, North Africa, and West Asia region: a report from the Pediatric Oncology East and Mediterranean (POEM) group. Cancer 2020; 126: 4235–4245.
Google Scholar | Crossref | Medline4. Sullivan, M, Bouffet, E, Rodriguez-Galindo, C, et al. The COVID-19 pandemic: a rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global. Pediatr Blood Cancer 2020; 67: e28409.
Google Scholar | Crossref | Medline5. Landmann, E, Burkhardt, B, Zimmermann, M, et al. Results and conclusions of the European intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma. Haematologica 2017; 102: 2086–2096.
Google Scholar | Crossref | Medline6. de Rojas, T, Pérez-Martínez, A, Cela, E, et al. COVID-19 infection in children and adolescents with cancer in Madrid. Pediatr Blood Cancer 2020; 67: e28397.
Google Scholar | Crossref | Medline7. Rouger-Gaudichon, J, Thébault, E, Félix, A, et al. Impact of the first wave of COVID-19 on pediatric oncology and hematology: a report from the French Society of Pediatric Oncology. Cancers 2020; 12: 3398.
Google Scholar | Crossref8. Avanzato, VA, Matson, MJ, Seifert, SN, et al. Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer. Cell 2020; 183: 1901–1912.
Google Scholar | Crossref | Medline9. Li, L, Zhang, W, Hu, Y, et al. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial. JAMA 2020; 324: 460–470.
Google Scholar | Crossref | Medline10. Hueso, T, Pouderoux, C, Péré, H, et al. Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19. Blood 2020; 136: 2290–2295.
Google Scholar | Crossref | Medline11. Libster, R, Pérez Marc, G, Wappner, D, et al. Early high-titer plasma therapy to prevent severe covid-19 in older adults. N Engl J Med 2021; 384: 610–618.
Google Scholar | Crossref | Medline12. Bade, NA, Lu, C, Patzke, CL, et al. Optimizing pegylated asparaginase use: an institutional guideline for dosing, monitoring, and management. J Oncol Pharm Pract 2020; 26: 74–92.
Google Scholar | SAGE Journals13. Samanta, J, Gupta, R, Singh, MP, et al. Coronavirus disease 2019 and the pancreas. Pancreatology 2020; 20: 1567–1575.
Google Scholar | Crossref | Medline14. Han, H, Yang, L, Liu, R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med 2020; 58: 1116–1120.
Google Scholar | Crossref | Medline